These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30858445)

  • 1. Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate.
    Aharoni R; Schottlender N; Bar-Lev DD; Eilam R; Sela M; Tsoory M; Arnon R
    Sci Rep; 2019 Mar; 9(1):4140. PubMed ID: 30858445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glatiramer acetate guards against rapid memory decline during relapsing-remitting experimental autoimmune encephalomyelitis.
    LoPresti P
    Neurochem Res; 2015 Mar; 40(3):473-9. PubMed ID: 25481047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis.
    Aharoni R; Eilam R; Lerner S; Shavit-Stein E; Dori A; Chapman J; Arnon R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
    Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
    J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
    Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
    J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis.
    Aharoni R; Arnon R; Eilam R
    J Neurosci; 2005 Sep; 25(36):8217-28. PubMed ID: 16148229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
    Aharoni R; Sasson E; Blumenfeld-Katzir T; Eilam R; Sela M; Assaf Y; Arnon R
    Exp Neurol; 2013 Feb; 240():130-44. PubMed ID: 23153580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory therapy with glatiramer acetate reduces endoplasmic reticulum stress and mitochondrial dysfunction in experimental autoimmune encephalomyelitis.
    Makar TK; Guda PR; Ray S; Andhavarapu S; Keledjian K; Gerzanich V; Simard JM; Nimmagadda VKC; Bever CT
    Sci Rep; 2023 Apr; 13(1):5635. PubMed ID: 37024509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glatiramer Acetate: from Bench to Bed and Back.
    Arnon R; Aharoni R
    Isr Med Assoc J; 2019 Mar; 21(3):151-157. PubMed ID: 30905097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.
    Aharoni R; Eilam R; Domev H; Labunskay G; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19045-50. PubMed ID: 16365293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis.
    Eilam R; Segal M; Malach R; Sela M; Arnon R; Aharoni R
    Glia; 2018 May; 66(5):1098-1117. PubMed ID: 29424049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sildenafil on neuroinflammation and synaptic plasticity pathways in experimental autoimmune encephalomyelitis.
    Araújo SMDR; Duarte-Silva E; Marinho CGS; Oliveira WH; França MER; Lós D; Peron G; Tomaz L; Bonfanti AP; Verinaud L; Peixoto CA
    Int Immunopharmacol; 2020 Aug; 85():106581. PubMed ID: 32442900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
    Lalive PH; Neuhaus O; Benkhoucha M; Burger D; Hohlfeld R; Zamvil SS; Weber MS
    CNS Drugs; 2011 May; 25(5):401-14. PubMed ID: 21476611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
    Janssen A; Fiebiger S; Bros H; Hertwig L; Romero-Suarez S; Hamann I; Chanvillard C; Bellmann-Strobl J; Paul F; Millward JM; Infante-Duarte C
    PLoS One; 2015; 10(6):e0130251. PubMed ID: 26114502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate.
    Arnon R; Aharoni R
    J Neural Transm (Vienna); 2009 Nov; 116(11):1443-9. PubMed ID: 19669693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS.
    Häusler D; Hajiyeva Z; Traub JW; Zamvil SS; Lalive PH; Brück W; Weber MS
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32184341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis.
    Gilgun-Sherki Y; Panet H; Holdengreber V; Mosberg-Galili R; Offen D
    Neurosci Res; 2003 Oct; 47(2):201-7. PubMed ID: 14512144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent inhibition of GCPII to prevent and treat cognitive impairment in the EAE model of multiple sclerosis.
    Hollinger KR; Alt J; Riehm AM; Slusher BS; Kaplin AI
    Brain Res; 2016 Mar; 1635():105-12. PubMed ID: 26826008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.
    Herges K; Millward JM; Hentschel N; Infante-Duarte C; Aktas O; Zipp F
    PLoS One; 2011; 6(10):e25456. PubMed ID: 22022398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.